Evidence map›Paper›PMID 38769332›Full record

ArticleNature communications2024

Cytomegalovirus drives Vδ1

Samantha Chan, Benjamin Morgan, Michelle K Yong, Mai Margetts, Anthony J Farchione, Erin C Lucas, Jack Godsell, Nhi Ai Giang, Charlotte A Slade, Anouk von Borstel and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Oligoclonal expansion of atypical Vδ2Nature communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Expansion of effector memory Vδ2Frontiers in immunology · 2024
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samantha ChanImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-3785-7759
Benjamin MorganImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Michelle K YongVictorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-8692-4145
Mai MargettsImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-0615-1515
Anthony J FarchioneImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-5234-0259
Erin C LucasImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-3577-7605
Jack GodsellDepartment of Clinical Immunology & Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Nhi Ai GiangDepartment of Clinical Immunology & Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7909-8714
Charlotte A SladeImmunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Anouk von BorstelInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0002-3605-7936
Vanessa L Bryant *Immunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Lauren J Howson *Immunology Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. howson.l@wehi.edu.au.ORCID http://orcid.org/0000-0003-3522-4533

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 1161521Department of Health | National Health and Medical Research Council (NHMRC) 2007884Jack Brockhoff Foundation JBF 4847-2021
6 · The paper itself

Abstract

The function and phenotype of γδ T cells in the context of common variable immunodeficiency (CVID) has not been explored. CVID is a primary immunodeficiency disorder characterized by impaired antibody responses resulting in increased susceptibility to infections. γδ T cells are a subset of unconventional T cells that play crucial roles in host defence against infections. In this study, we aim to determine the roles and functions of γδ T cells in CVID. We observe a higher frequency of Vδ1

Indexed as

Common Variable ImmunodeficiencyCytomegalovirusCytomegalovirus InfectionsReceptors, Antigen, T-Cell, gamma-deltaAdolescentAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedT-Lymphocyte SubsetsViremiaYoung AdultReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID38769332
PMCPMC11106253

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.